Acute lung injury as an adverse event of gefitinib.
Inomata S, Takahashi H, Nagata M, Yamada G, Shiratori M, Tanaka H, Satoh M, Saitoh T, Sato T, Abe S.
Inomata S, et al. Among authors: tanaka h.
Anticancer Drugs. 2004 Jun;15(5):461-7. doi: 10.1097/01.cad.0000127666.12215.7b.
Anticancer Drugs. 2004.
PMID: 15166619
Clinical Trial.